Make more informed decisions through our In Vitro Contract Research Services
We offer standard and bespoke in vitro studies as a service to screen your novel therapeutic candidates, investigate mechanisms of action and fast-track clinical trial design. Our services are ideal for drug developers who need quick access to organ-on-a-chip (OOC) technology without the need to invest in equipment.
Partner with us to access over a decade of OOC expertise, the most human-relevant in vitro models available, our dedicated team of creative problem solvers, and a proven track record for delivering clinically translatable results.
Your dedicated contact will work with you to design and conduct studies that get results quickly and cost-effectively compared to animal studies. All studies are performed using PhysioMimix® technology to generate human-relevant data that improves your chances of clinical success.
Explore our services
NAFLD / NASH Services
Overcome the limitations of murine models through our complementary service to understand the human efficacy of novel anti-NASH therapeutics. Gain mechanistic insights from a range of disease markers (hepatic steatosis, inflammation, fibrosis) and target pathways.
Drug-induced liver injury Services
Our DILI Services offer a reliable tool for evaluating drug safety in a human-relevant system. We can evaluate multiple endpoints to establish a complete assessment of acute or chronic DILI risk using a wide range of clinically relevant endpoints to determine causality and mechanism of toxicity.
Take a step beyond what’s currently possible to gain deeper insights into the ADME properties of a wide variety of drug modalities. Identify and correlate human-specific metabolites with cell health or more accurately predict bioavailability versus animals to select candidates with desirable profiles.
Use Oncology Services to guide clinical study design for the rapid development of new therapeutics without xenografts. Perform unique studies using an in vitro microfluidic platform that replicates in vivo PK profiles to explore human PK/PD relationships, in vivo or in silico findings, drug dosing regimens, and combinations.